Marcellino K, Kelly W N
Total Therapeutic Management, Kennesaw, GA, USA.
Am J Health Syst Pharm. 2001 Aug 1;58(15):1399-405. doi: 10.1093/ajhp/58.15.1399.
Potential risk factors for and the preventability of drug-induced threats to life were studied. Case reports of adverse drug events (ADEs) published in Clin-Alert during 1977-97 were the source of information on drug-induced life threats. Patient, drug, and event variables were identified, and the causality, predictability, and preventability of each case were assessed. Data were entered into a relational database for analysis. The data indicated 846 drug-induced life threats. Seventy-four percent of the cases were assessed as definite or probable. Patients received usual or below-usual dosages in 89% of the cases. Patients tended to be middle-aged and only moderately ill. The drug categories most frequently associated with life threats were antimicrobials and central-nervous-system agents. Plasma drug level monitoring should have been performed in 127 cases but occurred only in 31 cases (24%). Event types were distributed as adverse drug reactions (50%), allergic reactions (35%), drug interactions (11%), and medication errors (4%). A commercial reference classified almost half of the drug interactions associated with a life threat as posing minimal or no potential risk to the patient. Half of the life-threatening events were judged to have been preventable; about half of these could have been prevented by a pharmacist. Litigation was reported for only 1% of the cases of drug-induced threats to life; judgments and settlements averaged $1.2 million. A review of published case reports of ADEs for 1977-97 yielded information on possible risk factors for drug-induced life threats and on which events may have been preventable.
对药物引起的生命威胁的潜在风险因素及可预防性进行了研究。1977 - 1997年发表在《临床警报》上的药物不良事件(ADEs)病例报告是药物引起生命威胁信息的来源。确定了患者、药物和事件变量,并评估了每个病例的因果关系、可预测性和可预防性。数据录入关系数据库进行分析。数据显示有846例药物引起的生命威胁。74%的病例被评估为明确或很可能。89%的病例中患者接受的是常用剂量或低于常用剂量。患者多为中年且病情中等。与生命威胁最常相关的药物类别是抗菌药物和中枢神经系统药物。127例本应进行血浆药物水平监测,但仅有31例(24%)进行了监测。事件类型分布为药物不良反应(50%)、过敏反应(35%)、药物相互作用(11%)和用药错误(4%)。一份商业参考文献将几乎一半与生命威胁相关的药物相互作用归类为对患者构成最小或无潜在风险。一半的危及生命事件被判定为可预防;其中约一半可由药剂师预防。只有1%的药物引起生命威胁病例报告了诉讼;判决和和解平均金额为120万美元。对1977 - 1997年发表的ADEs病例报告进行回顾,得出了关于药物引起生命威胁的可能风险因素以及哪些事件可能可预防的信息。